Nektar Therapeutics | Der Umsatz





Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 12.9M 450K 2025-09
ALKERMES USD 394.2M 3.5M 2025-09
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.84B 30M 2025-09
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 75.18B 710M 2025-12
Dr.Reddys Laboratories INR 87.27B 780M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exelixis USD 598.66M 860K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.18B 37.55M 2025-09
Halozyme Therapeutics USD 354M 148M 2025-09
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 157M 295M 2025-09
Ironwood Pharmaceuticals USD 122.06M 36.82M 2025-09
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
MacroGenics USD 72.84M 50.6M 2025-09
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xencor USD 21M 22.61M 2025-09


Nektar Therapeutics Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.